Help

BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Login Register Subscribe

Florida reaches opioid settlements with CVS, Teva, others

Reprints
opioids

(Reuters) — Florida has reached more than $878 million of settlements with CVS Health Corp. and three drug companies to resolve claims over their roles in fueling an opioid epidemic in the third most populous state.

CVS will pay $484 million; Teva Pharmaceutical Industries Ltd. will pay $194.8 million; Abbvie Inc.'s Allergan unit will pay $134.2 million; and Endo International PLC will pay $65 million, Florida Attorney General Ashley Moody said in a statement.

Most of the money will be spent on opioid abatement. Teva will also provide $84 million of its generic Narcan nasal spray, which can temporarily reverse the effects of opioid overdoses.

All of the companies denied wrongdoing in agreeing to settle.

The accords were announced nine days after Rhode Island reached similar settlements with Teva and Allergan that it valued at $107 million. 

CVS said settling was in the best interest of all parties, and that it would vigorously defend against other lawsuits relating to opioids. Teva said it “continues to actively negotiate a national settlement” of similar claims.

Abbvie and Endo were not immediately available for comment.